Skip to main content
Equibles

NOVYRA · NOVYRA PHARMACHEM LIMITED · Financials

Use NOVYRA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NOVYRA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
8.06 INR +0.38 (+4.95%) At close · Nov 13
Rebalance outlook locked
Market Cap
51.02M INR
Shares
6.33M
Volume · Nov 13 1200 Avg daily vol (11 sessions) 500

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
1.04M
FY2026 Revenue FY2025–FY2026
Net Income
-53.74M -8349.4%
FY2026 Net Income FY2025–FY2026
Operating Cash Flow
-37.23M -1909.2%
FY2026 Operating Cash Flow FY2025–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025
INR 60.61M 1.04M 0
INR 206K 289K 334K
INR 0 0 0
INR -54.03M -53.74M -636K
INR 0 0 0
INR -54.03M -53.74M -636K
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.